Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals
Arthritis Research & Therapy, 06/08/2012Mercer E et al.
Hydroxychloroquine (HCQ) use for 6 weeks in non diabetic obese subjects was associated with a significant increase in Insulin Sensitivity Index (ISI) and trends toward reduced insulin resistance and insulin secretion. These data suggest that HCQ, a common medication used to treat rheumatoid arthritis (RA), possesses beneficial effects upon insulin sensitization. Further study of the insulin sensitizing effects of HCQ in patients with RA is warranted.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.